She has served as a co-investigator in drug studies sponsored by Janssen, Ayerst and Bristol-Meyers, and has published and presented in the field of psychopharmacology. She has presented at meetings on the treatment of personality disorders, including dialectical behavior therapy; on assertive community treatment, and in the field of psychoanalysis, which is a form of intensive psychotherapy.She has served as a co-investigator in drug studies sponsored by Janssen, Ayerst and Bristol-Meyers, and has published and presented in the field of psychopharmacology.
She has presented at meetings on the treatment of personality disorders, including dialectical behavior therapy; on assertive community treatment, and in the field of psychoanalysis, which is a form of intensive psychotherapy.She has served as a co-investigator in drug studies sponsored by Janssen, Ayerst and Bristol-Meyers, and has published and presented in the field of psychopharmacology. She has presented at meetings on the treatment of personality disorders, including dialectical behavior therapy; on assertive community treatment, and in the field of psychoanalysis, which is a form of intensive psychotherapy.
She has served as a co-investigator in drug studies sponsored by Janssen, Ayerst and Bristol-Meyers, and has published and presented in the field of psychopharmacology. She has presented at meetings on the treatment of personality disorders, including dialectical behavior therapy; on assertive community treatment, and in the field of psychoanalysis, which is a form of intensive psychotherapy.